Sign In
Buy IMRA
$17.45
-0.680 (-3.75%)
At Close: Jun 03, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * AstraZe
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:40pm, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeu
The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
11:36am, Tuesday, 28'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) * AstraZeneca plc (NYSE: AZN) * Alnylam Pharmaceuti
Passage Bio (NASDAQ:IMRA) Downgraded by Zacks Investment Research
07:30am, Saturday, 25'th Apr 2020
Passage Bio (NASDAQ:IMRA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Saturday, Zacks.com reports. According to Zacks, “Imara Inc
Imara Strengthens Board of Directors With Appointment of Edward R. Conner, M.D.
11:00am, Thursday, 23'rd Apr 2020
Imara Inc. (IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemogl
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
10:39am, Thursday, 23'rd Apr 2020
These companies just raised significant cash to advance promising drug pipelines.
Keros Therapeutics Shares Climb 70% After First Post-Covid-19 Biotech IPO
09:31pm, Tuesday, 21'st Apr 2020
Company also exceeds offering target Continue reading...
Keros Therapeutics Shares Climb 70% After First Post-Covid-19 Biotech IPO
08:58pm, Tuesday, 21'st Apr 2020
Keros Therapeutics Shares Climb 70% After First Post-Covid-19 Biotech IPO, Stocks: KROS,XLRN,TSE:4503,BMY,FGEN,SRRA,IMRA,ZNTL, release date:Apr 21, 2020
Brokers Set Expectations for Passage Bio's Q1 2020 Earnings (NASDAQ:IMRA)
05:08am, Thursday, 09'th Apr 2020
Passage Bio (NASDAQ:IMRA) – Equities research analysts at SVB Leerink issued their Q1 2020 earnings per share estimates for Passage Bio in a report released on Monday, April 6th. SVB Leerink analyst
Zacks: Brokerages Set $30.00 Price Target for Passage Bio (NASDAQ:IMRA)
07:44am, Wednesday, 08'th Apr 2020
Passage Bio (NASDAQ:IMRA) has been given an average broker rating score of 1.25 (Strong Buy) from the two brokers that provide coverage for the company, Zacks Investment Research reports. One investme
Passage Bio (NASDAQ:IMRA) Coverage Initiated at Cowen
07:00am, Wednesday, 08'th Apr 2020
Research analysts at Cowen began coverage on shares of Passage Bio (NASDAQ:IMRA) in a report issued on Monday, Briefing.com Automated Import reports. The brokerage set an “outperform” rating and a
Fly Intel: Top five analyst initiations JAZZ;CLAR;IMRA;IDYA;SLAB
02:42pm, Monday, 06'th Apr 2020
Fly Intel: Top five analyst initiations JAZZ CLAR IMRA IDYA SLAB
Passage Bio (NASDAQ:IMRA) Coverage Initiated by Analysts at Morgan Stanley
11:20am, Monday, 06'th Apr 2020
Equities researchers at Morgan Stanley assumed coverage on shares of Passage Bio (NASDAQ:IMRA) in a report issued on Monday, Briefing.com Automated Import reports. The firm set an “overweight” rat
The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations
06:03pm, Sunday, 05'th Apr 2020
Biotech stocks went along with the broader market flow in the week ended April 3, with the COVID-19 pandemic dictating sentiment. The week witnessed a host of clinical readouts and pre-announcements i
Best ETFs for 2020: The Renaissance IPO ETF Got Major Help From Zoom
04:56pm, Friday, 27'th Mar 2020
The Renaissance IPO ETF could be one of the best ETFs this year as some of its holdings can soften the blow from the coronavirus pandemic.
